why choose us

First received: January 12, 2023

Clinical Trial: Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Nonsmall Cell Lung Cancer Stage III

Study Type: INTERVENTIONAL


Official Title: Phase II Pilot Study of Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer

Brief Summary: This research study aims to determine what effects (good and bad) Durvalumab has on participants and their cancer with a "quick start" of Durvalumab within 14 days of finishing chemotherapy and radiation.The study will also determine the logistic barriers to the quick start of Durvalumab.

Read more